- Previous Close
18.55 - Open
18.30 - Bid --
- Ask --
- Day's Range
16.70 - 18.30 - 52 Week Range
16.70 - 40.00 - Volume
114,410 - Avg. Volume
38,771 - Market Cap (intraday)
1.129B - Beta (5Y Monthly) -0.11
- PE Ratio (TTM)
-- - EPS (TTM)
-2.74 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Jun 20, 2023
- 1y Target Est
--
Kim Forest Enterprise Co., Ltd. provides precision medical products. It offers devices, reagents, and analysis pipelines to health care providers, which include screening tests for cancer and inherited diseases. The company also provides genetic testing, drug report, and monitoring tools for cancer patients; and a non-invasive genome-wide health assessment for healthy persons. In addition, it offers bioinformatics service items; prenatal test kits; and genetically modified models. Further, the company offers SARS-CoV-2 detection kits. The company was founded in 2004 and is headquartered in New Taipei City, Taiwan.
www.kimforest.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 6645.TW
View MorePerformance Overview: 6645.TW
Trailing total returns as of 4/9/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 6645.TW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 6645.TW
View MoreValuation Measures
Market Cap
1.03B
Enterprise Value
1.17B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.78
Price/Book (mrq)
1.61
Enterprise Value/Revenue
2.34
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-31.88%
Return on Assets (ttm)
-9.77%
Return on Equity (ttm)
-26.34%
Revenue (ttm)
501.53M
Net Income Avi to Common (ttm)
-159.88M
Diluted EPS (ttm)
-2.74
Balance Sheet and Cash Flow
Total Cash (mrq)
217.86M
Total Debt/Equity (mrq)
57.28%
Levered Free Cash Flow (ttm)
-239.01M